Dr Philips provides statistical consultancy services to the Pharmaceutical Industry based on 35+ years of experience working in the Pharmaceutical and Clinical Research Organisation (CRO) industries. Alan has experience of regulatory submissions in many therapeutic areas such as Biosimilars (Rituximab, Herceptin), CNS (depression, insomnia, Generalized Anxiety Disorder), Cardiovascular (Hypertension), Oncology (Breast Cancer) and Women’s Health (Hormone Replacement Therapy, Oral Contraceptives). For example, Alan developed and justified the sample size and statistical analysis strategy for managing missing data for a biosimilar development program for the FDA. He have also recently provided statistical support for clinical development plans in Osteogenesis Imperfecta, Sarcopenia and Chronic active antibody-mediated rejection (AMR) in Kidney transplant recipients. He represents clients at FDA and EMA regulatory meetings, as well as being an expert statistical member on DMCs.
Caidya Announces Strategic Combination with Simbec-Orion — Learn more here
Alan Philips
Drug Development Advisory Board
Get started with us today
Discover what’s possible when you have the right partner. Get in touch to see how we can support you.
Other board members
Anand Jain
Chairman of the Board
Fabrice Chartier
Chief Executive Officer
Mark Trus
Chief Financial Officer
Aize Smink
Chief Operating Officer
Ceri Edwards
Managing Director, Clinical Pharmacology
Nikola Strumberger
Chief Commercial Officer
Anita Cooper
Non-Executive Director
Adam Richardson
Non-Executive Director
Got a question? Get in Touch or Submit an RFI/RFP
Our team is on hand to answer any questions you might have relating to the work we do at Simbec-Orion. Just fill in the form below, making sure to tick the boxes that apply, and we’ll respond as quickly as we can.
Looking to volunteer for a clinical trial?
Visit our dedicated volunteer website here, or email [email protected]
Follow us on Social Media
Send us a message, we’ll respond as quickly as possible
Complete the form below, and we’ll get back to you as soon as possible regarding your query.